Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Clinical Trials in Zhengzhou, Henan

A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression